Plovanic William J. 4
4 · OBALON THERAPEUTICS INC · Filed May 17, 2018
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Award
Common Stock (Restricted Stock Award)
2018-05-15+45,000→ 45,000 total
Holdings
- 190,572
Common Stock
- 24,588(indirect: By Spouse)
Common Stock
- 24,700(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer.